Cargando…

Kynurenines as a Novel Target for the Treatment of Malignancies

Malignancies are unquestionably a significant public health problem. Their effective treatment is still a big challenge for modern medicine. Tumors have developed a wide range of mechanisms to evade an immune and therapeutic response. As a result, there is an unmet clinical need for research on solu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mor, Adrian, Tankiewicz-Kwedlo, Anna, Pawlak, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308824/ https://www.ncbi.nlm.nih.gov/pubmed/34201791 http://dx.doi.org/10.3390/ph14070606

Ejemplares similares

Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
por: Mor, Adrian, et al.
Publicado: (2021)

Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk—Review
por: Kiluk, Małgorzata, et al.
Publicado: (2021)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
por: Wesolowski, Jakub, et al.
Publicado: (2022)

Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
por: Mor, Adrian, et al.
Publicado: (2020)

Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer
por: Tankiewicz-Kwedlo, Anna, et al.
Publicado: (2018)

Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer
por: Tankiewicz‐Kwedlo, Anna, et al.
Publicado: (2018)

Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer
por: Rozkiewicz, Dariusz, et al.
Publicado: (2020)

Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
por: Kozieł, Kamila, et al.
Publicado: (2023)

The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
por: Broekhuizen, Michelle, et al.
Publicado: (2021)

Kynurenine Pathway—An Underestimated Factor Modulating Innate Immunity in Sepsis-Induced Acute Kidney Injury?
por: Krupa, Anna, et al.
Publicado: (2022)

Synthesis and cellular effects of novel 1,3,5-triazine derivatives in DLD and Ht-29 human colon cancer cell lines
por: Wróbel, Agnieszka, et al.
Publicado: (2019)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017)

Phytochemical treatments target kynurenine pathway induced oxidative stress
por: Parasram, K.
Publicado: (2017)

T cell fat catabolism: A novel target for kynurenine?
por: Puccetti, Paolo, et al.
Publicado: (2021)

A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

Kynurenine pathway in kidney diseases
por: Zakrocka, Izabela, et al.
Publicado: (2021)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
por: Rad Pour, Soudabeh, et al.
Publicado: (2020)

Tryptophan: Its Metabolism along the Kynurenine, Serotonin, and Indole Pathway in Malignant Melanoma
por: Hubková, Beáta, et al.
Publicado: (2022)

Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
por: Lu, Yifei, et al.
Publicado: (2020)

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
por: Zinger, Anna, et al.
Publicado: (2011)

Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
por: Krishnamurthy, Shivani, et al.
Publicado: (2021)

The Kynurenine Pathway in Stem Cell Biology
por: Jones, Simon P., et al.
Publicado: (2013)

The Footprint of Kynurenine Pathway in Cardiovascular Diseases
por: Ala, Moein, et al.
Publicado: (2022)

Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
por: Chen, Ping, et al.
Publicado: (2023)

Kynurenine Aminotransferase Isozyme Inhibitors: A Review
por: Nematollahi, Alireza, et al.
Publicado: (2016)

Kynurenine Pathway in Psoriasis—a Promising Link?
por: Stepaniuk, A., et al.
Publicado: (2023)

A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics
por: Maddison, Daniel C., et al.
Publicado: (2020)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Kynurenine pathway metabolism and neuroinflammatory disease
por: Braidy, Nady, et al.
Publicado: (2017)

Kynurenine pathway in Parkinson's disease—An update
por: Venkatesan, Dhivya, et al.
Publicado: (2020)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis
por: Basson, Charlise, et al.
Publicado: (2023)

Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms
por: Wences Chirino, Tiffany, et al.
Publicado: (2023)

Cluster headache and kynurenines
por: Tuka, Bernadett, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ct535nop558g5l1t8rac4cd7dn